CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Alkermes Pharma Ireland Limited v. Intellipharmaceutics Corporation

1:12-cv-00834

Overview

Case Number 1:12-cv-00834
Filing Date 2012-06-29
Status Terminated
Termination Date 2013-05-21
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Intellipharmaceutics Ltd. Operating Company

Represented By

1 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Intellipharmaceutics Corporation NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Plaintiff

Alkermes Pharma Ireland Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 21 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (21): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6228398
Multiparticulate modified release composition
Filed: 2000-05-08
Issued: 2001-05-08
Expired (Term Ended)
Expires: 2020-05-08
US6730325
Multiparticulate modified release composition
Filed: 2001-05-07
Issued: 2004-05-04
Expired (Term Ended)
Expires: 2021-05-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

5

Dispositive

0

Granted

0

Denied

0

Pending / Review

5

Motions by Category

Procedural / Extension Motion 5

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the defendants to move, answer, or otherwise respond to the Complaint to March 15, 2013 - filed by Alkermes Pharma Ireland Limite...
Entry #15 • 2013-02-28 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer Complaint to February 28, 2013 - filed by Alkermes Pharma Ireland Limited, Intellipharmaceutics Corporation, Intellipharmac...
Entry #14 • 2013-02-04 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME by which Defendants Intellipharmaceuticals Corporation and Intellipharmaceutics Ltd. must move, answer, or otherwise respond to the C...
Entry #13 • 2013-01-04 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME BY WHICH THE DEFENDANTS MUST MOVE, ANSWER, OR OTHERWISE RESPOND TO THE COMPLAINT to JANUARY 7, 2013 - filed by Alkermes Pharma Irelan...
Entry #12 • 2012-11-29 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer Complaint to December 7, 2012 - filed by Alkermes Pharma Ireland Limited, Intellipharmaceutics Corporation, Intellipharmace...
Entry #11 • 2012-10-25 Document →

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT filed against Intellipharmaceutics Corporation, Intellipharmaceutics Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-1099244.) - filed by Alkermes Pharma Ireland Limited. (Attachments: # 1 Exhibit A - B, # 2 Civil Cover Sheet)(dmp, ) (Entered: 06/29/2012)

Entry #1 • 2012-06-29
1
Pleading / Complaint

COMPLAINT filed against Intellipharmaceutics Corporation, Intellipharmaceutics Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-1099244.) - filed by Alkermes Pharma Ireland Limited. (Attachments: # 1 Exhibit A - B, # 2 Civil Cover Sheet)(dmp, ) (Entered: 06/29/2012)

Entry #1 • 2012-06-29
2
Pleading / Complaint

COMPLAINT filed against Intellipharmaceutics Corporation, Intellipharmaceutics Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-1099244.) - filed by Alkermes Pharma Ireland Limited. (Attachments: # 1 Exhibit A - B, # 2 Civil Cover Sheet)(dmp, ) (Entered: 06/29/2012)

Entry #1 • 2012-06-29
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dmp, ) (Entered: 06/29/2012)

Entry #2 • 2012-06-29
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/16/2012. Date of Expiration of Patent: 6,228,398-11/01/2019; 6,730,325-11/01/2019.Thirty Month Stay Deadline: 11/16/2014. (dmp, ) (Entered: 06/29/2012)

Entry #3 • 2012-06-29
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc